Novel Pharma

Novel Pharma has an experienced team of researchers with knowledge, experience, and skills across the entire value chain of orphan drug development for rare diseases, from candidate discovery to preclinical, clinical trials, and commercialization.Researchers at Novel Pharma have an outstanding track record in developing Hunterase IV-ERT and ICV-ERT treatments for Hunter syndrome.